Diabetes

  • A black reader is shown on top of a phone with a blood glucose reading.
    Image attribution tooltip
    Permission granted by Senseonics
    Image attribution tooltip

    Senseonics receives FDA clearance for one-year CGM

    Commercial partner Ascensia is in discussions with insulin pump manufacturers to create an automated insulin delivery system.

    By • Sept. 17, 2024
  • A rounded deivce that says "Accu-Chek" is in front of a phone showing a glucose prediction
    Image attribution tooltip
    Permission granted by Roche
    Image attribution tooltip

    Roche to launch new CGM in Europe in ‘coming weeks’

    Roche will roll out its Accu-Chek Smartguide in the Netherlands, Switzerland and Germany. The company hopes to stand out from competitors with features to predict hypoglycemia.

    By • Sept. 12, 2024
  • A person stands with a white, circular device attached to their upper arm.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Dexcom, Abbott OTC glucose sensors add to busy year for diabetes tech

    New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

    By • Sept. 11, 2024
  • A person eats oatmeal with berries, and a phone on the counter shows their current glucose levels.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott debuts Lingo over-the-counter CGM in the US

    Priced at $49 for one 14-day sensor, or $89 per month, Abbott’s offering is competitive with Dexcom’s Stelo sensor. 

    By • Sept. 6, 2024
  • A person on a stationary bike wears a small, white patch on their upper arm.
    Image attribution tooltip
    Permission granted by Abbott Laboratories
    Image attribution tooltip

    Abbott partners with maker of ‘bionic pancreas’

    Abbott will integrate its latest glucose sensor with Beta Bionics’ automated insulin delivery system. 

    By • Sept. 5, 2024
  • Embecta CEO Dev Kurdikar stands at a podium that says "Nasdaq" while people clap around him.
    Image attribution tooltip
    Permission granted by Nasdaq
    Image attribution tooltip

    Embecta gets FDA nod for insulin patch pump

    Embecta’s first patch pump features a larger insulin reservoir, based on feedback from people with Type 2 diabetes.

    By • Sept. 3, 2024
  • A photo shows Insulet Chief Medical Officer Trang Ly
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip
    Q&A

    Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care

    Automated insulin delivery for Type 2 patients can help change minds among physicians who have been reluctant to prescribe pump therapy, the chief medical officer said in an interview.

    By • Aug. 27, 2024
  • A person runs in a soccer field wearing two white devices taped to their upper arms.
    Image attribution tooltip
    Courtesy of Insulet
    Image attribution tooltip

    Insulet expands Omnipod 5 pump to people with Type 2 diabetes

    The FDA clearance marks the first automated insulin delivery system for people with Type 2 diabetes.

    By • Aug. 26, 2024
  • A person playing pickleball wears a circular patch on their upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom prices first over-the-counter glucose monitor

    Known as Stelo, the device is intended for people who don’t take insulin and costs $89 per month.

    By • Aug. 26, 2024
  • A person smiles while wearing a square device on their hip and a round device on their upper arm.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem warns iPhone app still draining insulin pump batteries

    Despite a software update in March, users are still reporting that the app is rapidly depleting their insulin pump batteries, causing unexpected shutdowns.

    By • Aug. 15, 2024
  • A person stands outside wearing a small, square device with a cord on their belt.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Abbott, Medtronic partner on diabetes tech

    Abbott will develop a glucose sensor that can only connect with Medtronic's insulin delivery technology.

    By • Aug. 7, 2024
  • A person playing a guitar in front of a microphone holds up a phone with a blood glucose reading on it.
    Image attribution tooltip
    Courtesy of Ascensia Diabetes Care
    Image attribution tooltip
    Q&A

    Ascensia’s new head of CGM talks plans for a 365-day sensor

    Brian Hansen recently joined Ascensia, which markets Senseonics’ implantable glucose sensors. The current version lasts 180 days, but Senseonics is seeking FDA approval for a one-year sensor.

    By • Aug. 6, 2024
  • A person holds a yellow and blue pen, showing the expiration date.
    Image attribution tooltip
    Joe Raedle via Getty Images
    Image attribution tooltip

    Patient shares a day in the life with diabetes at FDA’s first Home Health Hub meeting

    The initiative, led by new CDRH Acting Director Michelle Tarver, is intended to improve health equity by including people’s living conditions in device design.

    By • July 30, 2024
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip
    Q&A

    Tandem CMO shares Mobi feedback, expansion plans

    MedTech Dive caught up with Chief Medical Officer Jordan Pinsker to talk about early feedback on Tandem’s smallest insulin pump and what’s next for the device.

    By • July 29, 2024
  • Professional photo of Kevin Sayer
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom shares plunge on lower sales outlook

    “I’m just kind of in shock,” an analyst said on the earnings call, asking for more detail on the forecast cut.

    By • July 26, 2024
  • A person on a stationary bike wears a small, white patch on their upper arm.
    Image attribution tooltip
    Permission granted by Abbott Laboratories
    Image attribution tooltip

    Abbott recalls Freestyle Libre 3 sensors due to incorrect glucose readings

    A spokesperson for Abbott said the recall “may impact less than 1% of Libre 3 users in the U.S.”

    By • July 26, 2024
  • Embecta CEO Dev Kurdikar stands at a podium that says "Nasdaq" while people clap around him.
    Image attribution tooltip
    Permission granted by Nasdaq
    Image attribution tooltip

    Diabetes device firm Embecta considers sale: Financial Times

    Two years after Embecta spun out of BD, the firm is now exploring a potential sale, the Financial Times reported. 

    By • July 22, 2024
  • An image of the Abbott Volt pulsed field ablation catheter.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott previews PFA, over-the-counter CGM markets

    Electrophysiology sales held up against rivals’ launches of pulsed field ablation systems. Meanwhile, Abbott is gauging sales of its first OTC CGMs. 

    By • July 18, 2024
  • Intuitive Surgical's da Vinci 5 robotic system.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip

    J&J, Abbott and Intuitive start medtech earnings season

    The companies’ financial results will offer a glimpse at the current health of medtech markets.

    By • July 16, 2024
  • Roche Pharmaceutical Group's office building in Shanghai, China
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    Roche wins CE mark for its first CGM

    The clearance positions Roche to challenge Abbott and Dexcom for the European continuous glucose monitor market.

    By • Updated July 10, 2024
  • A person digs with a spade in a raised garden bed. They wear a gray sticker on their upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Abbott and Dexcom are launching the first over-the-counter CGMs. Here are 7 questions on the new tech.

    Experts expect the release of new over-the-counter glucose monitors in the U.S. to fuel more widespread use of the devices.

    By • June 26, 2024
  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta
    Image attribution tooltip

    Embecta touts its insulin patch pump at ADA

    Embecta said its device, with a larger insulin reservoir, addresses an unmet need for people with Type 2 diabetes.

    By • June 25, 2024
  • A picture of a man looking at a diabetes tracking app on his phone.
    Image attribution tooltip
    Retrieved from Ascensia Diabetes Care on June 25, 2024
    Image attribution tooltip

    Senseonics tips 365-day CGM to double 2025 sales

    Senseonics is in talks with insulin pump manufacturers about integrating its implantable Eversense continuous glucose monitor with their devices.

    By • June 25, 2024
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes

    At the American Diabetes Association meeting, Insulet shared study results showing improvements in blood glucose and quality of life.

    By • June 24, 2024
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem names Jean-Claude Kyrillos as chief operating officer

    The appointment gives Kyrillos a leading role in work to expand the insulin delivery company’s global operations and achieve profitable growth.

    By • June 21, 2024